CAZ Investments’s iShares Biotechnology ETF IBB Stock Holding History

CAZ Investments’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,000	Closed	-$2.53M	–	33
2025 Q2	$2.53M	Buy	20,000 +9,300	+87%	+$1.14M	14.33%	2
2025 Q1	$1.37M	Hold	10,700	–	–	9.84%	2
2024 Q4	$1.42M	Hold	10,700	–	–	2.03%	8
2024 Q3	$1.56M	Hold	10,700	–	–	0.94%	7
2024 Q2	$1.47M	Hold	10,700	–	–	0.51%	8
2024 Q1	$1.47M	Hold	10,700	–	–	2.66%	8
2023 Q4	$1.45M	Hold	10,700	–	–	1.94%	13
2023 Q3	$1.31M	Hold	10,700	–	–	2.38%	10
2023 Q2	$1.36M	Hold	10,700	–	–	1.61%	9
2023 Q1	$1.38M	Hold	10,700	–	–	2.8%	8
2022 Q4	$1.41M	Hold	10,700	–	–	2.52%	7
2022 Q3	$1.25M	Hold	10,700	–	–	5.25%	5
2022 Q2	$1.26M	Buy	10,700 +1,000	+10%	+$119K	3.86%	6
2022 Q1	$1.26M	Buy	+9,700	New	+$1.26M	0.72%	13
2020 Q3	–	Sell	-16,300	Closed	-$2.23M	–	40
2020 Q2	$2.23M	Buy	+16,300	New	+$2.08M	2.09%	15

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CAZ Investments's IBB Position: Q3 2025 in Review

CAZ Investments sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 20,000 shares — an estimated $2.53M sold.

CAZ Investments first reported a position in IBB in Q2 2020 and held it in 15 quarters. The position peaked at $2.53M in Q2 2025. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

CAZ Investments reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
CAZ Investments sold 20,000 iShares Biotechnology ETF shares in Q3 2025, an estimated $2.53M.
CAZ Investments first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 15 quarters.
CAZ Investments's iShares Biotechnology ETF position peaked at $2.53M in Q2 2025.
803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on CAZ Investments's 13F filing for Q3 2025, filed 12 Nov 2025.